Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Effects of 7-keto lithocholic acid (7-KLCA) on the gut microbiome and metabolic risk factors.

Official title: The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.

Run by University of Reading · NCT07499414 · Data updated 2026-11-12

We will test whether taking the bile acid supplement 7-keto lithocholic acid (7-KLCA) changes the gut microbiome and metabolic risk markers in healthy adults.

More Healthy Aging trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Reading
Academic / other
Locations1 site (Reading)
StatusRecruiting
StartedApril 6, 2026
Main results expectedApril 5, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 30, 2026
Trial IDNCT07499414 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18–65 without gastrointestinal disorders, not taking pro- or prebiotic supplements, following a non-restrictive diet, and meeting hemoglobin and consent requirements.

Probably not a fit

People with gastrointestinal disorders (such as IBS or IBD), those on restrictive diets (vegan, keto, or fasting), minors or adults over 65, or anyone currently using probiotic/prebiotic products are unlikely to be eligible or to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls healthy adults aged 18–65 who will receive oral 7-KLCA or a maltodextrin comparator and be followed over the treatment period. Stool samples and blood tests will be collected before and after the intervention to measure changes in gut microbial composition and markers of metabolic health such as lipids and glucose. Participants must avoid pro- or prebiotic supplements for at least four weeks prior and follow a non-restrictive diet during the study. The trial builds on in vitro and preclinical data showing 7-KLCA is metabolized to UDCA and can promote beneficial bacteria, testing whether those effects occur in humans.

Why it matters

Potential benefit: If successful, this supplement could increase beneficial gut bacteria and improve metabolic risk markers, suggesting a new preventive approach for metabolic health.

How similar studies have gone: Related bile acid treatments like UDCA have been used clinically and shown to shift gut bacterial populations, while 7-KLCA has supportive in vitro and preclinical evidence but remains relatively untested in humans.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Volunteer is healthy (good physical and mental condition, disease-free, with haemoglobin levels between 138 - 172 g/L for male and between 121 and 151 g/L for female) at the time of pre-examination
* Volunteer is aged ≥ 18 to ≤ 65 years for the duration of the study
* Volunteer is able and willing to comply with the study instructions
* Volunteer is suitable for participation in the study according to the investigator/study personnel
* Volunteer is able to give informed consent
* Volunteer must be following a non-restrictive diet according to the investigator/study personnel (no vegan, keto or fasting diets)
* Volunteer has not consumed pro- or prebiotic supplements or food products for a minimum of 4 weeks prior to starting the intervention.
* Volunteer has no gastrointestinal disorders

Exclusion Criteria:

* No command of any local language
* Gastrointestinal disorders including IBS, IBD or other conditions that might affect the gut environment
* Food allergies or intolerances
* Using drugs (e.g. antibiotics) influencing gastrointestinal function (12 weeks before intervention)
* Use of laxatives
* Clinically significant diabetes (plasma glucose test, fasting blood glucose \> 6.5 mmol/l (120 mg/dL)
* Volunteers currently involved or will be involved in another clinical/ food study for the duration of this study
* History of drug (pharmaceutical or recreational) or alcohol abuse.
* If participants are pregnant or are lactating
* Regular intake of probiotic or prebiotic supplements
* Smoker
* Those who follow extreme diets (Keto-diet, Atkins diet, vegan)
* Those taking prescribed medication for existing health condition(s)
* Those with a pacemaker

Where it's running

  • Hugh Sinclair Unit, Harry Nursten Building, University of Reading, Whiteknights Campus, RG6 6UR
    Reading, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.